Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn, Robert A. Salata, Peter Mugyenyi et al.|The Lancet HIV|2019Cited by 39
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settingsTanakorn Apornpong, Monica Gandhi, Beatriz Grinsztejn et al.|AIDS|2021Cited by 5